Phase II randomized trial of first-line pembrolizumab and vorinostat in patients with metastatic NSCLC (mNSCLC): Final results von Saltos, Andreas Nicholas, Tanvetyanon, Tawee, Creelan, Ben C., Shafique, Michael Rahman, Antonia, Scott Joseph, Haura, Eric B., Zheng, Hong, Yu, Xiaoqing, Saller, James Joseph, Viracacha, Sebastian, Thapa, Ram, Boyle, Theresa A., Chen, Dung-Tsa, Beg, Amer A, Gray, Jhanelle Elaine

Volltext

A phase 1 first-in-human study of interferon beta (IFNβ) and membrane-stable CD40L expressing oncolytic virus (MEM-288) in solid tumors including non–small-cell lung cancer (NSCLC)... von Saltos, Andreas Nicholas, Arrowood, Christy, Beasley, Georgia, Ronald, James, El-Haddad, Ghassan, Guerra-Guevara, Luiziane, Khan, Uzma, Wolf, Steven, Gu, Lin, Wang, Xiaofei F., Foresman, Dana, Yu, Xiaoqing, Cantwell, Mark J., Antonia, Scott Joseph, Beg, Amer A, Ready, Neal E.

Volltext

The final analysis of a phase I/II study of nivolumab, ipilimumab combined with nintedanib in advanced non-small cell lung cancer von Puri, Sonam, Tanvetyanon, Tawee, Creelan, Ben C., Shafique, Michael Rahman, Saltos, Andreas Nicholas, Chiappori, Alberto, Haura, Eric B., Thapa, Ram, Chen, Dung-Tsa, Boyle, Theresa A., Antonia, Scott Joseph, Gray, Jhanelle Elaine

Volltext

A phase II study of atezolizumab and cobimetinib in PD-1/PD-L1 inhibitor resistant or refractory non-small cell lung cancer: ETCTN #10166 von Liu, Stephen V., Hall, Richard Delmar, Saltos, Andreas Nicholas, Otterson, Gregory Alan, Tan, Ming Tony, Gnjatic, Sacha, Gentzler, Ryan D., Tanvetyanon, Tawee, Chen, Helen X., Sharon, Elad

Volltext

Trastuzumab deruxtecan (T-DXd; DS-8201) in patients with HER2-mutated metastatic non-small cell lung cancer (NSCLC): Interim results of DESTINY-Lung01 von Smit, Egbert F., Nakagawa, Kazuhiko, Nagasaka, Misako, Felip, Enriqueta, Goto, Yasushi, Li, Bob T., Pacheco, Jose Maria, Murakami, Haruyasu, Barlesi, Fabrice, Saltos, Andreas Nicholas, Perol, Maurice, Udagawa, Hibiki, Saxena, Kapil, Shiga, Ryota, Guevara, Ferdinand M., Acharyya, Suddhasatta, Shahidi, Javad, Planchard, David, Janne, Pasi A.

Volltext

Phase II randomized trial of first-line pembrolizumab and vorinostat in patients with metastatic NSCLC (mNSCLC) von Saltos, Andreas Nicholas, Tanvetyanon, Tawee, Creelan, Ben C., Shafique, Michael Rahman, Antonia, Scott Joseph, Haura, Eric B., Zheng, Hong, Barlow, Margaret, Saller, James, Castellano-Fornelli, Anna, Richards, Antoine, Thapa, Ram, Boyle, Theresa A., Chen, Dung-Tsa, Beg, Amer A, Gray, Jhanelle Elaine

Volltext

Phase I/Ib study of pembrolizumab and vorinostat in patients with metastatic NSCLC (mNSCLC) von Saltos, Andreas Nicholas, Tanvetyanon, Tawee, Williams, Charles C., Haura, Eric B., Creelan, Ben C., Antonia, Scott Joseph, Tchekmedyian, Nishan, Goas, Kristen, Mamplata, Trevor, Thapa, Ram, Chen, Dung-Tsa, Beg, Amer A., Gray, Jhanelle Elaine

Volltext

Phase I/Ib study of pembrolizumab and vorinostat in patients with metastatic NSCLC (mNSCLC): Updated results von Saltos, Andreas Nicholas, Tanvetyanon, Tawee, Haura, Eric B., Creelan, Ben C., Antonia, Scott Joseph, Shafique, Michael Rahman, Zheng, Hong, Dai, Wenjie, Chen, Zhihua, Saller, James Joseph, Tchekmedyian, Nishan, Goas, Kristen, Thapa, Ram, Boyle, Theresa A., Chen, Dung-Tsa, Beg, Amer A, Gray, Jhanelle Elaine

Volltext